Clinical trial
Daily vs Intermittent Restriction of Energy: Randomised Controlled Trial to Reduce Diabetes Risk (DIRECT)
NCT03689608 is registered in ClinicalTrials.gov with University of Adelaide as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Daily vs Intermittent Restriction of Energy: Randomised Controlled Trial to Reduce Diabetes Risk (DIRECT)
- Lead sponsor
- University of Adelaide
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 26, 2018
- Completion date
- November 30, 2021
- Enrollment
- 209 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
individuals at risk of developing diabetes